SOP Guide for Pharma

Manufacturing: SOP for Conducting Microbial Monitoring during Filling Process – V 2.0

Manufacturing: SOP for Conducting Microbial Monitoring during Filling Process – V 2.0

Standard Operating Procedure for Conducting Microbial Monitoring during Filling Process


Department Manufacturing
SOP No. SOP/MFG/175/2025
Supersedes SOP/MFG/175/2022
Page No. Page 1 of 15
Issue Date 24/06/2025
Effective Date 25/06/2025
Review Date 24/06/2026

1. Purpose

This SOP defines the process for conducting microbial monitoring during the aseptic filling of sterile injectable products. The objective is to detect and control microbial contamination in critical manufacturing environments, ensuring product sterility and regulatory compliance.

2. Scope

This SOP is applicable to microbial monitoring

activities carried out during the aseptic filling of vials, ampoules, and prefilled syringes in ISO Class 5 (Grade A) and surrounding ISO Class 7 (Grade B) cleanroom environments.

3. Responsibilities

  • Microbiology Analyst: To perform routine microbial sampling as per protocol.
  • Manufacturing Operator: To cooperate during monitoring and prevent contamination.
  • IPQA Officer: To oversee sampling integrity and environment conditions.
  • QC Microbiology Supervisor: To ensure compliance with testing schedules and review results.

4. Accountability

The Head of Quality Control is accountable for ensuring that microbial monitoring activities are carried out effectively, deviations are investigated, and results are recorded and reported in a timely manner.

5. Procedure

5.1 Preparation

  1. Verify calibration and cleanliness status of environmental monitoring instruments (e.g., air samplers, settle plates, contact plates).
  2. Ensure media used (TSA plates, SDA plates) are within expiry and approved for use.
  3. Label all media with batch number, sample point ID, date, and time before sampling.
  4. Ensure sampling is performed by qualified microbiologists wearing sterile gowning.

5.2 Active Air Sampling

  1. Use a calibrated air sampler positioned in critical areas (e.g., near filling heads, stopper bowls).
  2. Set sample volume (usually 1000 L for Grade A areas) and run per standard protocol.
  3. Record data in the Environmental Monitoring Log (Annexure-1).

5.3 Passive Air Sampling (Settle Plates)

  1. Place TSA plates exposed for 4 hours in Grade A and B areas, covering representative zones (e.g., filling line, operator working bench).
  2. Avoid placing plates in areas with strong airflow or vibrations.
  3. Retrieve plates using aseptic technique and transfer to incubation area.

5.4 Surface Monitoring (Contact Plates)

  1. Monitor critical surfaces like:
    • Gloved hands
    • Filling machine parts
    • Work surfaces
    • Container closure contact areas
  2. Press contact plate gently for 10 seconds without movement.
  3. Replace lids and label with details.
  4. Document surface locations sampled (Annexure-2).

5.5 Personnel Monitoring

  1. Sample personnel gloves, sleeves, and chest area at the end of filling operation.
  2. Any personnel entering Grade A zones must be monitored at least once per shift.
  3. Record findings under Annexure-3.

5.6 Incubation and Result Interpretation

  1. Incubate TSA plates at 30-35°C for 48–72 hours and then at 20–25°C for an additional 72 hours.
  2. SDA plates used for fungal detection should be incubated at 20-25°C for 5–7 days.
  3. Count colony-forming units (CFUs) and compare to alert and action limits as defined by the site’s Environmental Monitoring Program.
  4. Record all observations and deviations in Annexure-4.

5.7 Action on Out-of-Limit Results

  1. If action limits are breached:
    • Immediately notify QA and halt aseptic operation if applicable.
    • Initiate deviation report and root cause investigation.
    • Repeat sampling and increase frequency if required.
  2. Record incident in the Deviation Form (Annexure-5).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • CFU: Colony Forming Units
  • QC: Quality Control
  • TSA: Tryptic Soy Agar
  • SDA: Sabouraud Dextrose Agar
  • IPQA: In-Process Quality Assurance

7. Documents

  1. Environmental Monitoring Log – Annexure-1
  2. Surface Monitoring Log – Annexure-2
  3. Personnel Monitoring Record – Annexure-3
  4. Microbial Count Log – Annexure-4
  5. Deviation Form – Annexure-5

8. References

  • EU GMP Annex 1: Manufacture of Sterile Medicinal Products
  • WHO TRS 961 Annex 6 – GMP for sterile pharmaceutical products
  • USP <1116> – Microbiological Evaluation of Cleanrooms

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Microbiology Executive QA Executive Head QA
Department Quality Control Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Environmental Monitoring Log

Date Location Method CFU Count Analyst
24/06/2025 Filling Hood Active Air Sampling 1 Rajesh Kumar

Annexure-2: Surface Monitoring Log

Date Surface Area Location CFU Analyst
24/06/2025 Gloved Hand Filling Line A 0 Sunita Reddy

Annexure-3: Personnel Monitoring Record

Date Employee Name Location Glove CFU Chest CFU
24/06/2025 Vikram Singh Grade A – Filling Line B 0 0

Annexure-4: Microbial Count Log

Sample ID Date Location Result Limit Status
SP-AIR-2025-015 24/06/2025 Grade A Filling 0 CFU Action Limit = 1 CFU Compliant

Annexure-5: Deviation Form

Date Area Deviation Immediate Action Approved By
23/06/2025 Filling Zone B 2 CFU on Glove Line Stopped, Re-gowning QA Manager

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New SOP QA Head
24/06/2025 2.0 Added updated alert limits and risk actions Annual Review QA Head
Exit mobile version